IDDST-2024 (Europe)

Scientific Program

IDDST 10: Inflammation, Immunological Diseases Time: 08:30-12:00, June 19, 2024 (Wednesday); Place: Romeo, 1F, Radisson Blu Beke Hotel

Chair	Dr. Kathleen M. Smith, Senior Principal Research Scientist, AbbVie, USA

08:30-08:35	Chair’s Introduction
08:35-09:05	Title: Resolution Pharmacology : A Changing Paradigm in the Treatment of Inflammation Dr. Marc Dubourdeau, Director, AMBIOTIS SAS, France
09:05-09:35	Title: Persistence of Inflammatory Phenotype in Residual Psoriatic Plaques in Patients on Effective Biologic Therapy Dr. Kathleen M. Smith, Senior Principal Research Scientist, AbbVie, USA
09:35-10:05	Title: External Validation and Evaluation of the European League Against Rheumatism / American College of Rheumatology Classification Criteria for Adult Idiopathic Inflammatory Myopathies in an Australian Cohort Dr. Gabor Major, Director of Rheumatology, Hunter New England Health, Australia
10:05-10:30	Coffee Break
10:30-11:00	Title: Human Bone Marrow Stromal Cells Modulate the Pro-Inflammatory Character of BAL Cells Derived from Patients with Sarcoidosis in vitro Dr. Joseph Fontana, Senior Research Physician, National Institutes of Health, USA
11:00-11:30	Title: Systemic Sclerosis (Scleroderma): Challenges and Opportunities in Clinical Development of Novel Interventions Dr. Mario Ehlers, Associate Head of Medicine, Boehringer Ingelheim Pharmaceuticals Inc, USA
11:30-12:00	Title: Infectious-Immune Axis Leading to Neuro-immune Disease Dr. Isaac Melamed, Medical Director, IMMUNOe Health Centers, USA

IDDST 11: Clinical Trials, Cardiovascular & Metabolic Disorders Time: 08:30-11:45, June 19, 2024 (Wednesday); Place: Venice, 1F, Radisson Blu Beke Hotel

Chair	Dr. Charu Gautam, Clinical Pharmacologist, Gujarat University, India
Co-Chair	Dr. Gitanjali Srivastava, Professor of Medicine, Pediatrics & Surgery, Vanderbilt University, USA

08:30-08:35	Chair’s Introduction
08:35-09:00	Title: Hybrid Treatment of an Infected TEVAR Stent Graft with Bacteriophages Dr. Justus Gross, Head of Vascular Surgery, Rostock University Medical Center, Germany
09:00-09:25	Title: Clinical Studies for Complex Generic Molecules Dr. Charu Gautam, Clinical Pharmacologist, Gujarat University, India
09:25-09:50	Title: New Small Molecule Medications for Lowering Plasma Lp(a) Dr. Gert M. Kostner, Emeritus Professor, Medical University of Graz, Austria
09:50-10:15	Title: Drug Development: Challenges in Conducting Healthy Human Clinical Studies Dr. Murali Mohan Pendela, Chief Scientific Officer & Business Development, Avant Sante Research Center S.A de C.V., Mexico
10:15-10:30	Coffee Break
10:30-10:55	Title: Pharmacological Pioneers: Sculpting the Obesity Landscape with the Hammer of Novel Drug Therapies and Chisel of Sustained Weight Maintenance Dr. Gitanjali Srivastava, Professor, Pediatrics & Surgery, Vanderbilt University, USA
10:55-11:20	Title: Site-directed Resiniferatoxin Injections for Permanent Pain Relief Dr. Arpad Szallasi, Professor, Semmelweis University, Hungary
11:20-11:45	Title: Glucokinase Activators as Antidiabetic Drugs Dr. Nicolai Doliba, Associate Professor, University of Pennsylvania, USA

IDDST 12: Video Presentation

01	Title: TBD Dr. Arnima Bisht, Senior Director, Oxford BioTherapeutics, USA
02	Title: Effective Antimicrobial Agents Based on Ring-Substituted Hydroxyarylcarboxylic Acids Dr. Josef Jampilek, Professor, Palacky University Olomouc, Czech Republic
03	Title: Biophysical Perspective of Intracellular Delivery Dr. Karina Kwapiszewska, Assistant Professor, Institute of Physical Chemistry, Polish Academy of Sciences, Poland
04	Title: Allogeneic Cell Therapies for the Precise Immunomodulation of Rare Diseases Dr. Oscar Segurado, Chief Medical Officer, ASC Therapeutics, USA
05	Title: The Tumor Suppressor TRAF3 is a Novel Regulator of Myeloid-derived Suppressor Cell Expansion during Chronic Inflammation Dr. Ping Xie, Associate Professor, Rutgers University, USA
06	Title: LA1011 as a Therapeutic for Alzheimer's Disease Dr. Chrisostomos Prodromou, Senior Lecturer, University of Sussex, UK
07	Title: Application of Process Analytical Technology (PAT) in the Pharmaceutical Industry: Facilitating Pharmaceutical Processing to Industry 4.0 Dr. Hanzhou Feng, Associate Principal Scientist, Merck & Co., Inc., USA
08	Title: Transcriptomic Signatures Associated with Mortality in Newly Diagnosed Multiple Myeloma Patients Dr. Olayinka Adebayo, Senior Scientist, Clinical Pharmacology, Johnson & Johnson, USA